Twist Bioscience - About the company
Twist Bioscience is a public company based in San Francisco (United States), founded in 2013 by Emily Leproust, and . It operates as a Developer of a semiconductor-based DNA synthesis platform. Twist Bioscience has raised $321M in funding from investors like Fidelity Investments, Illumina and Paladin Capital. The company has 197 active competitors, including 89 funded and 30 that have exited. Its top competitors include companies like Amyris, Syngenta and AskBio.
Company Details
Developer of a semiconductor-based DNA synthesis platform. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA which is used in diverse fields of medicine, agriculture, industrial chemicals and data storage. It offers synthetic genes, oligo pools, and NGS target enrichment to support research and innovation
- Website
- Social
- Email ID
- @twistbioscience.com
Key Metrics
Founded Year
2013
Location
San Francisco, United States
Stage
Public
Total Funding
in 11 rounds
Latest Funding Round
Investors
Ranked
6th among 197 active competitors
Annual Revenue
as on Sep 30, 2022
Employee Count
as on Sep 30, 2023
Investment & Acquisitions
Abveris &
Similar Companies
Amyris &
Exit Details
Public
Legal entities associated with Twist Bioscience
Twist Bioscience is associated with 3 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Feb 03, 2013 | $204M (as on Sep 30, 2022) | 510 | 504 | |
Aug 22, 2021 | $4.63M (as on Sep 30, 2022) | 769 | 152 | |
Dec 31, 1999 | - | 564 | 465 |
Get your free copy of Twist Bioscience's company profile
Twist Bioscience's funding and investors
Twist Bioscience has raised a total funding of $321M over 11 rounds. Its first funding round was on Feb 07, 2014.
Twist Bioscience has 38 institutional investors including Fidelity Investments, Illumina and Paladin Capital. There are 3 Angel Investors in Twist Bioscience.
Here is the list of recent funding rounds of Twist Bioscience:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Apr 02, 2018 | $50M | Series F | 5565631 | 2655070 | - |
Dec 29, 2017 | $74.9M | Series E | 8042020 | 7633432 | |
Jun 14, 2017 | $27M | Series E | 5946588 | 3439839 |
Access funding benchmarks and valuations. Sign up today!View details of Twist Bioscience's funding rounds and investors
Twist Bioscience's founders and board of directors
The founders of Twist Bioscience are Emily Leproust, and . Emily Leproust is the CEO of Twist Bioscience. Emily Leproust has founded 1 more company - Petri.
View details of Twist Bioscience's Founder profiles and Board Members
Twist Bioscience's employee count trend
Twist Bioscience has 919 employees as of Sep 23. The total employee count is 7.1% lower than what it was in Sep 22. Here is Twist Bioscience's employee count trend over the years:
Uncover Twist Bioscience's growth story! Sign up today!Twist Bioscience's Competitors and alternates
Top competitors of Twist Bioscience include Amyris, Syngenta and AskBio. Here is the list of Top 10 competitors of Twist Bioscience, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | Hercules Capital, TPGÌý&²¹³¾±è;Ìý | 80/100 |
2nd | Syngenta 2000, Basel (Switzerland), Acquired | Provider of crop inputs for farming | - | 78/100 | |
3rd |  AskBio 2001, Durham (United States), Acquired | Provider of gene and protein therapies to treat various diseases | $235M | TPG, Golden Valley CapitalÌý&²¹³¾±è;Ìý | 74/100 |
4th | Sherlock 2019, Watertown (United States), Acquired | Provider of a diagnostic platform for DNA and RNA detection | $111M | , Catalio Capital ManagementÌý&²¹³¾±è;Ìý | 73/100 |
5th | Ginkgo Bioworks 2008, Boston (United States), Public | Provider of gene editing-based cultured ingredients for agriculture industry | $796M | General Atlantic, T. Rowe PriceÌý&²¹³¾±è;Ìý | 71/100 |
6th |  2013, San Francisco (United States), Public | Developer of a semiconductor-based DNA synthesis platform | $321M | Foresite Capital, Bay City CapitalÌý&²¹³¾±è;Ìý | 64/100 |
7th |  Asimov 2017, Boston (United States), Series B | AI-based computer-aided designing tool for drug discovery | $209M | CPP Investments, DCVCÌý&²¹³¾±è;Ìý | 69/100 |
8th | Antheia 2013, Palo Alto (United States), Series B | Genetically engineered yeast cells to produce medicinal products | $96.4M | SVB, Oxford FinanceÌý&²¹³¾±è;Ìý | 69/100 |
9th | Nuclera Nucleics 2013, Cambridge (United Kingdom), Series C | Developer of a desktop bioprinter to produce genes and proteins | $164M | Puhua Capital, Future Planet CapitalÌý&²¹³¾±è;Ìý | 69/100 |
10th | Ansa Biotechnologies 2017, Berkeley (United States), Series A | Provider of DNA synthesis technology using enzymes | $82M | RA Capital Management, MubadalaÌý&²¹³¾±è;Ìý | 68/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Twist Bioscience's competitors? Click to see the top ones
Twist Bioscience's Investments and acquisitions
Twist Bioscience has acquired 3 companies including Abveris, iGenomX and Genome Compiler Corporation. Twist Bioscience has not made any investments as of now. Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Nov 25, 2021 | Acquisition | 2014 | Quincy, United States | |
Jun 30, 2021 | Acquisition | - | ||
Apr 06, 2016 | Acquisition | - |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Twist Bioscience
Reports related to Twist Bioscience
Here is the latest report on Twist Bioscience's sector:
View
News related to Twist Bioscience
Media has covered Twist Bioscience for a total of 37 events in the last 1 year, 18 of them have been about company updates and 6 about partnerships.
•
•
MarketBeat•Apr 06, 2025•Twist Bioscience
•
•
MarketBeat•Mar 27, 2025•Twist Bioscience,
•
•
•
Seeking Alpha•Feb 03, 2025•Twist Bioscience
•
•
•
Seeking Alpha•Nov 18, 2024•Twist Bioscience
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Twist Bioscience
When was Twist Bioscience founded?
Twist Bioscience was founded in 2013.Where is Twist Bioscience located?
Twist Bioscience is located in San Francisco, United States.When was the latest funding round of Twist Bioscience?
Twist Bioscience's latest funding round was on Apr 02, 2018.What is the annual revenue of Twist Bioscience?
Annual revenue of Twist Bioscience is £3.61²Ñ as on Sep 30, 2022.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Pubcare - Fukuoka based, 2020 founded, Unfunded company
- Artesian Scrubbing Bubbles - Martinsville based, Unfunded company
- Three Point O Labs - Hyderabad based, 2022 founded, Unfunded company
- All Klaipeda Hotels - Klaipeda based, 2016 founded, Unfunded company
- Grandmas Jam House - 1995 founded, Unfunded company
- Supple Bodies - Salt Lake City based, 2004 founded, Unfunded company
